LECOM Health Corry Memorial Hospital (CMH) has successfully launched a Positron Emission Tomography and Computed Tomography (PET/CT) Amyloid Imaging Program in partnership with Vantage Mobile Services to assist in diagnosing cognitive impairment. CMH is the first Vantage facility to offer advanced neurology PET/CT imaging.
The program features the Neuraceq® amyloid PET scan, an FDA-approved brain imaging technology used to detect amyloid buildup—a key indicator of Alzheimer’s disease. These scans help physicians determine the cause of memory issues and guide treatment options.
“We are thrilled to offer the Neuraceq PET scan because knowing a diagnosis gives patients the opportunity to plan ahead and receive treatment with FDA-approved amyloid-targeting therapies,” said Danielle Hansen, D.O., Regional President of LECOM Health. “Corry Memorial Hospital launched mobile PET/CT exams in April 2022 to identify cancer and certain brain diseases, such as Alzheimer’s. We continue to explore advancements in diagnostic care and innovative treatments to pave the way toward wellness and whole-body care.”…